Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Listed Companies

Climate change action dropped against Channel
Listed Companies

Climate change action dropped against Channel

A major climate change case against Channel Infrastructure has been discontinued. 

Victoria Young 17 May 2024
Millennium & Copthorne plans new hotel in Whangārei CBD
Listed Companies

Millennium & Copthorne plans new hotel in Whangārei CBD

The company has a site under contract for $2.24 million.

John Anthony 26 Apr 2024
How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024